A review of etoposide in patients with non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

A review of etoposide in patients with non-small-cell lung cancer (NSCLC)

Published:1982-06 Issue: Volume:9 Page:115-118
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Itri L.M.,Gralla R.J.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference23 articles.

1. Vinca alkaloids and epipodophyllotoxies;Bender,1979

2. Cis-dichlorodiammineplatinum (II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum (II), adriamycin and cyclophosphamide in combination for adenocarcinoma of the lung;Briteill;Cancer Treat. Rep.,1978

3. Phase II study of high dose cis-dichlorodiammineplatinum (II) in the treatment of non-small cell lung cancer;Casper;Cancer Treat. Rep.,1979

4. A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141540) in the treatment of bronchogenic carcinoma;Cavalli;Tumori,1977

5. Cis-platinum and ctoposide (DDP/VP 16-213) in the treatment of non-small-cell lung cancer;Cavalli,1981

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploitation of the Bulgarian Flora's Biodiversity as a Source of Immunomodulatory and/or Antineoplastic Agents: Current Challenges and Perspectives;Biotechnology & Biotechnological Equipment;2007-01

2. Advances in Cytotoxic Chemotherapy for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer;Seminars in Oncology;2005-06

3. Non-Small Cell Lung Cancer: A Study of Long-Term Survival after Vinorelbine Monotherapy;The Oncologist;2000-04-01

4. Prolonged Infusion of Etoposide in Patients with Advanced Non-Small Cell Lung Cancer;American Journal of Clinical Oncology;1996-10

5. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial;Annals of Oncology;1996-10